Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Paper of the day - Scan and treat osteoporosis strategy 'cost effective in older men'

Screening men over 65 who have had a fracture and all men over 80 with a DXA scan and then treating osteoporotic men for five years with bisphosphonates may be cost effective, according to a new study.

The study, based on US health costs which tend to be more expensive than those in the UK, concluded that the strategy has a cost per quality-adjusted life year of $50,000 (about £25,000).

The study also suggested that giving a DXA scan to all men aged 70 or over and then treating those identified with osteoporosis would be cost effective if the cost of bisphosphonates was less than $500 (about £250). Generic weekly alendronate in the UK costs about £100 for a year.

The absolute risk of a fracture over 10 years was reduced by between 2 and 4.5% depending on age, with a relative risk reduction of about 10%.

JAMA 2007; 298(6): 629-637.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say